Author: Wang, Shuang; Zhao, Jijun; Wang, Hongyue; Liang, Yingjie; Yang, Niansheng; Huang, Yuefang
Title: Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome Cord-id: sut3nf2a Document date: 2015_4_29
ID: sut3nf2a
Snippet: NLRP3 inflammasome is engaged in the inflammatory response during acute lung injury (ALI). Purinergic receptor P2X7 has been reported to be upstream of NLRP3 activation. However, the therapeutic implication of P2X7 in ALI remains to be explored. The present study used lipopolysaccharide (LPS)-induced mouse model to investigate the therapeutic potential of P2X7 blockage in ALI. Our results showed that P2X7/NLRP3 inflammasome pathway was significantly upregulated in the lungs of ALI mice as compar
Document: NLRP3 inflammasome is engaged in the inflammatory response during acute lung injury (ALI). Purinergic receptor P2X7 has been reported to be upstream of NLRP3 activation. However, the therapeutic implication of P2X7 in ALI remains to be explored. The present study used lipopolysaccharide (LPS)-induced mouse model to investigate the therapeutic potential of P2X7 blockage in ALI. Our results showed that P2X7/NLRP3 inflammasome pathway was significantly upregulated in the lungs of ALI mice as compared with control mice. P2X7 antagonist A438079 suppressed NLRP3/ASC/caspase 1 activation, production of IL-1β, IL-17A and IFN-γ and neutrophil infiltration but not the production of IL-10, resulting in a significant amelioration of lung injury. Moreover, blockage of P2X7 significantly inhibited NLRP3 inflammasome activation and IL-1β production in bone marrow derived macrophages. Similar results were obtained using another P2X7 inhibitor brilliant blue G (BBG) in vivo. Thus, pharmacological blockage of P2X7/NLRP3 pathway can be considered as a potential therapeutic strategy in patients with ALI.
Search related documents:
Co phrase search for related documents- absence presence and active process: 1, 2, 3
- absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and adaptive innate: 1, 2
- absence presence and adaptive innate immune response: 1
- activation signal and acute ards respiratory distress syndrome: 1, 2, 3, 4
- activation signal and adaptive innate: 1, 2, 3, 4, 5
- activation signal and adaptive innate immune response: 1, 2, 3
- activation signal and lps administration: 1
- activation signal and lps induce: 1, 2
- active process and acute ards respiratory distress syndrome: 1
- active process and adaptive innate: 1
- acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute ards respiratory distress syndrome and adaptive innate immune response: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lps administration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and lps induce: 1, 2, 3, 4, 5, 6
- adaptive innate and lps administration: 1
- adaptive innate and lps challenge: 1
Co phrase search for related documents, hyperlinks ordered by date